KRO-14758

GGTI-DU 40

892654-56-7
98% min.
scale-up (10-1,000 kg)
C30H31Cl2N5O3S

KRO-10217

Benzenesulfonamide,2-bromo-N-[4-chloro-3-[[(3R)-1-methyl-3-pyrrolidinyl]oxy]phenyl]-4,5-dimethoxy; 2-Bromo-N-[4-chloro-3-[[(3R)-1-methyl-3-pyrrolidinyl]oxy]phenyl]-4,5-dimethoxy-benzenesulfonamide

474960-44-6
98% min.
scale-up (10-1,000 kg)
C19H22BrClN2O5S

KRO-15825

d3-udenafil

1032008-25-5
98% min.
scale-up (10-1,000 kg)
C25H33D3N6O4S

KRO-08805

5-[2-propyloxy-5-(2-(1-Methylpyrrolidin-2-yl)ethylaMinosulphonyl)phenyl]-1-Methyl-3-propyl-6,7-dihydro-1H-pyrazolo(4,3-d)pyriMidin-7-one; Zydena; Udenafi; 5-(2-Propyloxy-5-(1-methyl-2-pyrollidinylethylamidosulfonyl)phenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo(4,3-D)pyrimidine-7-one; Da-8159; 5-[2-propyloxy-5-[2-(1-Methyl-2-pyrrolidinyl)ethylaMinosulfonyl]phenyl]-1-Methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyriMidine-7-one; 3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-N-[2-(1-methyl-2-pyrrolidinyl)ethyl]-4-propoxybenzenesulfonamide

268203-93-6
98% min.
scale-up (10-1,000 kg)
C25H36N6O3S2

KRO-32350

[(3r)-4-(1-chloropyrido[3,4-d]pyridazin-4-yl)-3-methyl-1-piperazinyl]phenyl-methanone

1133749-93-5
98% min.
scale-up (10-1,000 kg)
C19H18ClN5O

KRO-19271

6-(2-isopropyl-6-methyl-phenyl)-8-(2-methoxy-phenyl)-2-methylamino-8h-pyrido[2,3-d]pyrimidin-7-one

1398510-37-6
98% min.
scale-up (10-1,000 kg)


KRO-47007

1-propanol, 3-[[4-[4-[(3-chlorophenyl)amino]-1,3,5-triazin-2-yl]-2-pyridinyl]amino]-

652153-35-0
98% min.
scale-up (10-1,000 kg)
C17H17ClN6O

KRO-16689

4-amino-n-(1h-indazol-5-yl)-2-phenyl-butyramide

574726-31-1
98% min.
scale-up (10-1,000 kg)
C17H18N4O

KRO-09823

N-(1,1-DIMETHYLETHYL)-3-[[5-METHYL-2-[[4-(4-METHYL-1-PIPERAZINYL)PHENYL]AMINO]-4-PYRIMIDINYL]AMINO]BENZENESULFONAMIDE; 1M3; Kinome_702; N-tert-butyl-3-(5-methyl-2-(4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-ylamino)benzenesulfonamide

936091-14-4
98% min.
scale-up (10-1,000 kg)
C26H35N7O2S

KRO-10085

kro-10085

627908-92-3
98% min.
scale-up (10-1,000 kg)
C23H27FN4O4

KRO-01283

Motesanib Base

453562-69-1
98% min.
scale-up (10-1,000 kg)
C22H23N5O

KRO-01787

4-[2-[(2R,3R)-3-(2,5-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]-1,3-thiazol-4-yl]benzonitrile; Isavuconazole; UNII-60UTO373KE; Bal4815

241479-67-4
98% min.
scale-up (10-1,000 kg)
C22H17F2N5OS

KRO-19023

TAK-242 (S enantiomer); TAK-242 S enantimer; CS-1214; TAK 242

243984-10-3
98% min.
scale-up (10-1,000 kg)
C15H17ClFNO4S

KRO-14702

Hesperadin; N-[(3Z)-2-oxo-3-[phenyl-[4-(piperidin-1-ylmethyl)anilino]methylidene]-1H-indol-5-yl]ethanesulfonamide; UNII-PTR491OS14; hesperadin

422513-13-1
98% min.
scale-up (10-1,000 kg)
C29H32N4O3S

KRO-09747

TSU-68; TSU-68,SU6668,Orantinib); Orantinib

252916-29-3
98% min.
scale-up (10-1,000 kg)
C18H18N2O3

KRO-13839

KRN-951; AV951,AV-951; Tivozanib (AV-951); Tivozanib; AV951 Tivozanib; AV951; Tivozanib,AV951,AV-951

475108-18-0
98% min.
scale-up (10-1,000 kg)
C22H19ClN4O5

KRO-16743

Cyclohexaneacetic acid,|A-[(2-pyrazinylcarbonyl)amino]-,(|AS); (S)-cyclohexyl-[(pyrazine-2-carbonyl)-amino]-acetic acid; CYC045; cyclohexyl-[(pyrazine-2-carbonyl)-amino]-acetic acid; (S)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetic acid

848777-30-0
98% min.
scale-up (10-1,000 kg)
C13H17N3O3

KRO-34671

3-AMINO-4-CYCLOBUTYL-2-OXOBUTANAMIDE HCL; 3-Amino-4-cyclobutyl-2-oxobutanamide hydrochloride

817169-86-1
98% min.
scale-up (10-1,000 kg)
C8H15ClN2O2

KRO-16532

trans-3-amino-4-cyclobutyl-2-hydroxybutanamide hydrochloride; 3-amino-4-cyclobutyl-2-hydroxybutanamide hydrochloride; cis-3-amino-4-cyclobutyl-2-hydroxybutanamide hydrochloride; |A-Amino-|A-hydroxycyclobutanebutanamide Hydrochloride; Beta-Amino-Alpha-hydroxycyclobutanebutanamide Hydrochloride

394735-23-0
98% min.
scale-up (10-1,000 kg)
C8H17ClN2O2

KRO-19148

6-Amino-3,4-dihydro-2H-isochinolinon-(1); QC-9362; 6-aminoisoquinolone; 6-amino-3,4-dihydroisoquinolin-1(2H)-one

22246-00-0
98% min.
scale-up (10-1,000 kg)
C9H10N2O